Chau DYS, Brown VB, Mather ML, Hutter V, Tint NL, Dua HS, Rose FRAJ, Ghaemmaghami AM. 2012. Tissue transglutaminase (TG-2) modified amniotic membrane: a novel scaffold for biomedical applications. Biomedical Materials. 1(7):4
Dalleywater WJ, Chau DYS, Ghaemmaghami AM. 2012. Tissue transglutaminase treatment leads to concentration-dependent changes in dendritic cell phenotype- implications in the role of transglutaminase in coeliac disease. BMC Immunology. 13(20):1-10.
Nicholls F, Gorenkova N, Bible E, Franco C, Chau DYS, Shakesheff KM, West JL, Modo M. 2012. Improving the treatment of stroke through nanotechnology. In: Heiss JD, Kateb B, eds. Nanoneurosurgery and Nanoneuroscience. CRC Press
Bible E, Chau DYS, Alexander MR, Price J, Shakesheff KM, Modo M., 2010. Transplantation of Human NSCs on VEGF-Releasing Microparticle Scaffolds in a Stroke Model. Cell Transplantation, 19(3):331-332.
Chau DYS, Tint NL, Collighan RJ, Griffin M, Dua HS, Shakesheff KM, Rose FRAJ, 2010. The visualisation of vitreous using surface modified poly(DL-lactic-co-glycolic acid) microparticles. British Journal of Ophthalmology, 94:648-653.
Garcia-Nieto S, Johal RK, Shakesheff KM, Emara M, Royer PJ, Chau DYS, Shakib F, Ghaemmaghami AM., 2010. Laminin and fibronectin treatment leads to generation of dendritic cells with superior endocytic capacity. PLoS ONE, 19.
Saif J, Schwarz TM, Chau DYS, Henstock J, Sami P, Leicht SF, Hermann PC, Alcala S, Mulero F, Shakesheff KM, Heeschen C, Aicher A, 2010. Combination of injectable multiple growth factor-releasing scaffolds and cell therapy as an advanced modality to enhance tissue neovascularization. Arterioscler Thromb Vasc Biol, (10):1897-1904.
Bible E, Chau DYS, Alexander MR, Price J, Shakesheff KM, Modo M. 2009. Attachment of stem cells to scaffold particles for intra-cerebral transplantation. Nature Protocols, 4(10):1440-1453.
Agahsi K, Chau DYS, Shakesheff KM. 2009. The effect of delivery via narrow-bore needles on mesenchymal cells. Regenerative Medicine, 4(1): 49-64.
Bible E, Chau DYS, Alexander MR, Price J, Shakesheff KM, Modo M. 2009. The support of neural stem cells transplanted into stroke-induced brain cavities by PLGA particles. Biomaterials, 30(16):2985-94.
Chau DYS, Agashi K, Shakesheff KM. 2008. Microparticles as tissue-engineering scaffolds: Manufacture, manipulation and modification. Materials Science Technology, 24(9):1031-1044.
Chau DYS, Collighan RJ, Griffin M. 2008. Collagen: Structure and modification for biomedical applications. In: Pannone PJ, ed. Trends in Biomaterial Research. NOVA Scientific Publishers, p143-190
Hou Q, Chau DYS, Pratoomsoot C, Tighe PJ, Dua HS, Shakesheff KM, Rose FRAJ. 2008. In situ gelling hydrogels incorporating microparticles as drug delivery carriers for regenerative medicine. Journal of Pharmaceutical Sciences, 97(9):3972-3980.
Chau DYS, Collighan RJ, Verderio EAM, Griffin M., 2006. Medical Implant Materials. Worldwide Patent: WO2006027622
Jones RA, Kotsakis P, Johnson TS, Chau DYS, Ali S, Melino G, Griffin M. 2006. Matrix changes induced by transglutaminase 2 lead to inhibition of angiogenesis and tumor growth. Cell Death and Differentiation, 13(9):1442-53.
Chau DYS, Collighan RJ, Verderio EAM, Addy VL, Griffin M. 2005. The cellular response to transglutaminase-cross-linked collagen. Biomaterials, 26(33):6518-29.
Chau DYS, 2004. Beauty is Only Skin Deep. British Leather Technology Journal, (1):7-9.
Chau DYS, Al-Rubeai M. 2004. Artificial selection of high proliferating and apoptosis-resistant NS0 cells for industrial production systems. In: Yagasaki K, Miura Y, Hatori M, Nomura Y, eds. Animal Cell Technology: Basics and Applied Aspects. 13. Kluwer Academic Publishers, p225-231